Recently, Academician Zhang Xumu from Southern University of Science and Technology (Shenzhen GreenKate Medicine) and his delegation visited Laviana Pharma  (Cangzhou) Co., Ltd. and Laviana Pharma  (Tianjin) Co., Ltd. for inspection and exchange. Mr. Chen Wenting, Chairman of Laviana Pharma , and Mr. Wang Jie, Group General Manager, along with other company leaders accompanied the visit.

Under the leadership of Mr. Wang Jie, the general manager of the group, Academician Zhang Xumu and his team first visited the GMP production base of Laviana Pharma . They focused on the intelligent central control room, gaining a detailed understanding of the company's advanced practices in intelligent production and green low-carbon environmental protection. Additionally, the academician team visited the corporate culture corridor and the technology achievements display area, highly praising the innovative R&D production capabilities and corporate culture of Laviana Pharma.

In the intelligent central control room, Mr. Wang Jie demonstrated to the visiting guests how Laviana Pharma  utilizes an intelligent system for unified management of on-site equipment. This system is capable of easily integrating multiple management systems such as SIS, PLC, MES, and ERP, achieving seamless connectivity between smart instrumentation devices, control systems, and the company's resource management systems, greatly enhancing production efficiency and management levels.

After the visit, both parties proceeded to the Laviana Pharma  Tianjin Research and Development Center for a tour and held an in-depth discussion there. During the meeting, Academician Zhang Xumu provided a detailed introduction to his research achievements in the medical field and engaged in an in-depth discussion with the Laviana Pharma  team about innovative technological applications in research and development production.

The visit of Academician Zhang Xumu and his team has brought valuable scientific concepts and technical guidance to Laviana Pharma . Laviana Pharma  will take this event as an opportunity to continue increasing R&D investment, actively seek external cooperation, expand production lines through diversified means, develop high-tech and new quality productivity, and continuously enhance the core competitiveness of the enterprise.